Insider Trading & Ownership of JEAN JACQUES BIENAIME

Location: Palo Alto, CA
Summary: The estimated net worth of JEAN JACQUES BIENAIME is at least $57,266,536 dollars as of 12 Jun 2025. JEAN JACQUES BIENAIME is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $55.58M. JEAN JACQUES BIENAIME is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.27M. JEAN JACQUES BIENAIME is the Director of Immunome Inc. and owns shares of Immunome Inc. (IMNM) stock worth about $341.6K. JEAN JACQUES BIENAIME is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $78.7K.
Signature: /s/ Sandra Stoneman, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when JEAN JACQUES BIENAIME files a new Insider Trading report.

Ownership of JEAN JACQUES BIENAIME

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
BMRN	BIOMARIN PHARMACEUTICAL INC	Director	$55,578,092			20 May 2024
INCY	INCYTE CORP	Director	$1,268,174			10 Jun 2025
IMNM	Immunome Inc.	Director	$341,572	+$165,054	+94%	10 Jun 2025
KROS	Keros Therapeutics, Inc.	Director	$78,698			04 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.